Class IITerminatedD-0648-2017
Drug recall · April 12, 2017
Cotellic recall
Why: Superpotent Drug: An oversized tablet was found in a bottle.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Cotellic (cobimetinib) Tablets, 20 mg, 63 count bottle, Rx Only, Made in Switzerland. Distributed by Genentech USA, Inc., South Francisco, CA. 94080, NDC 50242-717-01,UPC 3 50242-717-01.
- Lots / codes
B1009MC, B1009M9, B1009MA; Exp. 02/18 B1009MT 02/19
- Quantity
- 748 bottles
- Company
- Genentech Inc., South San Francisco, CA
- Distribution
- NJ and IL
- Initiated
- March 13, 2017 · Voluntary: Firm initiated
- Classified
- April 5, 2017
- Reported
- April 12, 2017
- Ended
- May 12, 2017
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.